AMOR-1

· Amorphical Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMOR-1, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults [Phase 2]

See pricing